Lisa Salberg, introduced as founder and CEO of the Hypertrophic Cardiomyopathy Association, addressed the council about generic drug quality, citing testing results she said showed 71.8% of generics as 'green' while ~15% were 'red' or 'yellow'; she urged the FDA for greater transparency and invited residents to a webinar.